A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

The medication may be in short supply, which can affect not only how much is available, but the cost as well. Another medicine, synagis, can also be given, but that is meant for kids younger than ...

NHS England » NHS to roll out long-lasting ‘suit of armour’ jab to protect thousands of premature babies from RSV ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all their hospitalizations. However, a study published in Morbidity and Mortality ...

In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the respiratory infection. When you purchase through links on our site, we may ...

Fiancé celebrities just welcomed a baby, and that infant has a health issue. Learn about the baby's problem and recovery ...

FDA approval of Merck’s RSV antibody drug, Enflonsia, makes it a direct competitor to Sanofi’s Beyfortus. The new Merck product is expected to be discussed by the CDC’s Advisory Committee on ...

Doctors and parents celebrated the major advances that came in 2023 to treat respiratory syncytial virus (RSV), which sends up to 80,000 children under age five to the hospital each year in the U ...

Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the treatment needed, and how long your recovery will likely be.

Experts say the drug will give thousands of vulnerable infants “their own suit of armour” for their first winter ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

RSV medication is in limited supply. Here's how else you can protect your family this holiday season.